For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

Scientific Program

FP23

684

Dr.Shashikala P
Membership No Author Name Email Mobile
2211 Dr.Shruthi Das Shetty shru2011@gmail.com 9902709499
Cornea, Ocular Surface and External Eye Diseases

Mitomycin C – as a primary therapy in management of all cases of Ocular surface squamous neoplasia. 

Purpose-Surgical excision with cryotherapy though gold standard in managing OSSN, primary medical therapy is steadily growing owing to its conservative advantages. The efficacy of topical mitomycin-C 0.04% as primary treatment for OSSN was investigated. The primary outcome measure was clinical tumor regression & secondary outcome measures included duration of treatment, side effects & recurrence. Methods -Study was on 06 patients with IC proven OSSN. All were treated with MMC eye drops 0.04% 4 times daily for 4-8weeks,weekly ON- OFF regimen with lubricants during OFF period. The study was conducted over 20months (June'24 -March'25)
Results-tumor regression in 5 & reduction in 1achieved over mean duration of 6 weeks. Most common side effect was SPK, dealt with lubricants. No recurrence occurred Conclusion-Topical chemotherapy may be considered as primary treatment in all OSSN as causes complete or partial tumor regression with negligible side effects before any surgical intervention.

Membership No Author Name Email Mobile
4124 Dr.MAGI JAGAN M magijagan@yahoo.com 9741905017
4591 Dr.Pooja Sajjan poojasajjan26@gmail.com 9740693427